Table 3.
Self-reported frequency of asthma medication use among Swedish competitive recreational athletes with self-reported asthma, that is, physician diagnosis of asthma and use of asthma medication during the last 12 months, in each of the competitions and pooled data.
| Never | Sometimes | <2 months | >2 months | Daily | ||
|---|---|---|---|---|---|---|
| CCR Lidingöloppet | SABA/LABA | 98 (15) | 295 (44) | 40 (6) | 83 (12) | 154 (23) |
| ICS | 319 (48) | 96 (15) | 41 (6) | 40 (6) | 166 (25) | |
| ICS + LABA | 439 (67) | 34 (5) | 16 (2) | 26 (4) | 139 (21) | |
|
| ||||||
| CCS Vasaloppet | SABA/LABA | 53 (16) | 178 (52) | 15 (4) | 31 (9) | 64 (19) |
| ICS | 182 (55) | 53 (16) | 18 (5) | 19 (6) | 62 (18) | |
| ICS + LABA | 203 (60) | 22 (7) | 9 (3) | 9 (3) | 93 (28) | |
|
| ||||||
| OWS Vansbrosimningen | SABA/LABA | 22 (10) | 99 (45) | 15 (7) | 21 (10) | 63 (29) |
| ICS | 97 (46) | 19 (9) | 8 (4) | 8 (4) | 79 (37) | |
| ICS + LABA | 148 (69) | 7 (3) | 3 (1) | 3 (1) | 52 (24) | |
|
| ||||||
| Pooled study population | SABA/LABA | 167 (15) | 531 (46) | 67 (6) | 126 (11) | 259 (22) |
| ICS | 563 (50) | 153 (14) | 64 (6) | 63 (5) | 283 (25) | |
| ICS + LABA | 736 (66) | 61 (6) | 27 (3) | 36 (3) | 262 (23) | |
SABA = short-acting beta-2-agonists; LABA = long-acting beta-2-agonists; ICS = inhaled corticosteroids. Data are presented as n (%).